NCT02498509View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

PHASE3CompletedINTERVENTIONAL
Enrollment

459

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

May 31, 2016

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

CKD-342

treatment for 4 weeks after randomization

DRUG

Mometasone furoate

treatment for 4 weeks after randomization

DRUG

Levocabastine HCL

treatment for 4 weeks after randomization

Trial Locations (1)

135-710

Samsung Medical Center, Irwon-dong

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY